Print Page | Contact Us | Sign In | Register
News & Press: Member News

Aratana Therapeutics Announces Launch of ENTYCE® (capromorelin oral solution)

Friday, October 13, 2017   (0 Comments)
Posted by: Dennis Ridenour
Share |

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative pet therapeutics, announced the Company is making ENTYCE® (capromorelin oral solution) commercially available to veterinarians in the United States for appetite stimulation in dogs.
READ MORE........